Similar articles

• Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications.

  Nussenblatt RB. Nussenblatt RB. Invest Ophthalmol Vis Sci. 1991 Dec;32(13):3131-41. Invest Ophthalmol Vis Sci. 1991. PMID: 1748544 Review. No abstract available.
• Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.

  Wildner G, Thurau SR. Wildner G, et al. Eur J Immunol. 1995 May;25(5):1292-7. doi: 10.1002/eji.1830250524. Eur J Immunol. 1995. PMID: 7774632
• Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease.

  Wildner G, Thurau SR. Wildner G, et al. Eur J Immunol. 1994 Nov;24(11):2579-85. doi: 10.1002/eji.1830241103. Eur J Immunol. 1994. PMID: 7957552
• S-antigen: molecular mimicry may play a role in autoimmune uveitis.

  Shinohara T, Singh VK, Yamaki K, Abe T, Tsuda M, Suzuki S. Shinohara T, et al. Prog Clin Biol Res. 1991;362:163-90. Prog Clin Biol Res. 1991. PMID: 2003125 Review. No abstract available.
• Autoimmunity in the eye and its regulation.

  Gery I, Streilein JW. Gery I, et al. Curr Opin Immunol. 1994 Dec;6(6):938-45. doi: 10.1016/0952-7915(94)90017-5. Curr Opin Immunol. 1994. PMID: 7710718 Review.